UTHR Financial Facts
Total revenues: 408.2MNet income per basic common share (in dollars per share): 3.75
See Full Income Statement
Marketable investments: 79.6M
Inventories, net: 92.4M
See Full Balance Sheet
United Therapeutics Corp. (UTHR) Earnings
|
Expand Research on UTHR
| Next EPS Date | 7/30/26 *Est. | EPS Growth Rate | -100.0% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | -1.2% | Revenue Growth Rate | -100.0% *Last Qtr. |
| Average % Move 1-Wk after EPS | +2.8% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
5/6/26  |
Q126 | N/A | $6.94 | N/A | N/A | $811.43M | N/A | N/A | N/A | ||
| 2/25/26 | Q425 | $7.70 | $7.10 | +$0.60 | $790.2M | $815.24M | N/A |  | | Details | |
| 10/29/25 | Q325 | $7.16 | $7.32 | -$0.16 | $799.5M | $812.87M | N/A | | | Details | |
| 7/30/25 | Q225 | $6.41 | $7.35 | -$0.94 | $798.6M | $804.98M | N/A | | | Details | |
| 4/30/25 | Q125 | $6.63 | $6.53 | +$0.10 | $794.4M | $728.34M | N/A | | | Details | |
| 2/26/25 | Q424 | $6.19 | $6.68 | -$0.49 | $735.9M | $739.92M | N/A | | | Details | |
| 10/30/24 | Q324 | $6.39 | $6.53 | -$0.14 | $748.9M | $722.95M | N/A | | | Details | |
| 7/31/24 | Q224 | $5.85 | $6.48 | -$0.63 | $714.9M | $689.93M | N/A | | | Details |
